Search
Categories


Posts Tagged ‘Dyslipidemia’

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Sunday, May 30th, 2010

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

PDE-5 inhibitor improves ED in men with dyslipidemia

Saturday, May 29th, 2010

Vardenafil (Levitra) significantly improves the ability of men with erectile dysfunction and
dyslipidemia to achieve and maintain an erection for successful sexual intercourse, according to a study presented
at the Sexual Medicine Society of North America winter scientific meeting in Chicago. (Source: UrologyTimes – Sexual Dysfunction)

PDE-5 inhibitor improves ED in men with dyslipidemia

Wednesday, May 26th, 2010

Vardenafil (Levitra) significantly improves the abi lity of men with erectile dysfunction and
dyslipidemia to achieve and maintain an erection for successful sexual intercourse, according to a study presented
at the Sexual Medicine Society of North America winter scientific meeting in Chicago. (Source: UrologyTimes – Sexual Dysfunction)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive (more…)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) In Men With Dyslipidemia, Including High Cholesterol

Friday, May 21st, 2010

Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held in (more…)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Thursday, March 4th, 2010

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

PDE-5 inhibitor improves ED in men with dyslipidemia

Tuesday, March 2nd, 2010

Vardenafil (Levitra) significantly improves the ability of men with erectile dysfunction and
dyslipidemia to achieve and maintain an erection for successful sexual intercourse, according to a study presented
at the Sexual Medicine Society of North America winter scientific meeting in Chicago. (Source: UrologyTimes – Sexual Dysfunction)

PDE-5 inhibitor improves ED in men with dyslipidemia

Monday, March 1st, 2010

Vardenafil (Levitra) significantly improves the ability of men with erectile dysfunction and
dyslipidemia to achieve and maintain an erection for successful sexual intercourse, according to a study presented
at the Sexual Medicine Society of North America winter scientific meeting in Chicago. (Source: UrologyTimes – Sexual Dysfunction)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) In Men With Dyslipidemia, Including High Cholesterol

Sunday, February 21st, 2010

Results of the first prospective t rial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held (more…)